BioNexus Gene Lab Corp (BGLC)
0.52
-0.02
(-4.41%)
USD |
NASDAQ |
May 24, 16:00
0.52
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Profit Margin (Quarterly): -4.36% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.36% |
| December 31, 2023 | 13.57% |
| September 30, 2023 | -102.2% |
| June 30, 2023 | -10.10% |
| March 31, 2023 | -2.91% |
| December 31, 2022 | -5.53% |
| September 30, 2022 | -3.01% |
| June 30, 2022 | -5.58% |
| March 31, 2022 | 0.56% |
| December 31, 2021 | 2.75% |
| September 30, 2021 | 8.26% |
| Date | Value |
|---|---|
| June 30, 2021 | 0.91% |
| March 31, 2021 | 9.82% |
| December 31, 2020 | -4.22% |
| September 30, 2020 | 7.59% |
| June 30, 2020 | -3.25% |
| March 31, 2020 | 34.84% |
| December 31, 2019 | -174.5% |
| September 30, 2019 | -91.13% |
| June 30, 2019 | -325.2% |
| March 31, 2019 | -218.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-325.2%
Minimum
Jun 2019
34.84%
Maximum
Mar 2020
-32.68%
Average
-3.13%
Median
Profit Margin (Quarterly) Benchmarks
| Balchem Corp | 12.09% |
| Friedman Industries Inc | 1.02% |
| Solitario Resources Corp | -- |
| Golden Minerals Co | -- |
| Paramount Gold Nevada Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.32% |
| Return on Assets | -26.58% |
| Return on Invested Capital | -32.32% |
| Gross Profit Margin (Quarterly) | 15.33% |
| Operating Margin (Quarterly) | -3.32% |
| Return on Net Operating Assets | -42.07% |